Durable Protection after Anti?SARS-CoV-2 Monoclonal Antibody Therapy

被引：0
作者：
Misch, Elizabeth A. [1 ]
机构：
[1] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, 1685 Highland Dr,Med Fdn Centennial Bldg, Madison, WI 53705 USA
来源：
KIDNEY360 | 2022年 / 3卷 / 01期
关键词：
transplantation; COVID-19; kidney transplantation; monoclonal antibody therapy; SARS-CoV-2;
D O I：
10.34067/KID.0007722021
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 10
页数：3
相关论文
共 50 条
  • [31] An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2
    Sun, Chunyun
    Chi, Hang
    Yuan, Fei
    Li, Jing
    Yang, Ji
    Zheng, Aihua
    Wang, Fei
    Sun, Lingling
    Zhang, Yanjing
    Hu, Ping
    Jiao, Lihua
    Deng, Yongqiang
    Xie, Liangzhi
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (01) : 165 - 179
  • [32] Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines
    Yaqinuddin, Ahmed
    Shafqat, Areez
    Kashir, Junaid
    Alkattan, Khaled
    VACCINES, 2021, 9 (08)
  • [33] Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay
    Pallett, Scott J. C.
    Rayment, Michael
    Heskin, Joseph
    Mazzella, Andrea
    Jones, Rachael
    Mughal, Nabeela
    Randell, Paul
    Davies, Gary W.
    Moore, Luke S. P.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 104 (03)
  • [34] Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
    Taha, Yusri
    Wardle, Hayley
    Evans, Adam B.
    Hunter, Ewan R.
    Marr, Helen
    Osborne, Wendy
    Bashton, Matthew
    Smith, Darren
    Burton-Fanning, Shirelle
    Schmid, Matthias L.
    Duncan, Christopher J. A.
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2021, 20 (01)
  • [35] SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
    Fernando Garcia-Cruces-Mendeza, Jesus
    Corral-Gudino, Luis
    Piedad Del-Amo-Merino, Maria
    Maria Eiros-Bouza, Jose
    Dominguez-Gil Gonzalez, Marta
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 97 : 113 - 115
  • [36] Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
    Papadimitriou-Olivgeris, Matthaios
    Cipriano, Ana
    Guggisberg, Nicolas
    Kroemer, Marie
    Tschopp, Jonathan
    Manuel, Oriol
    Golshayan, Dela
    TRANSPLANT INTERNATIONAL, 2022, 35
  • [37] The role of SARS-CoV-2 antibody therapy in the treatment of COVID-19
    Fabian Akos
    ORVOSI HETILAP, 2021, 162 (51) : 2030 - 2039
  • [38] Durable antibody and effector memory T cell responses in breastmilk from women with SARS-CoV-2
    Narayanaswamy, Vignesh
    Pentecost, Brian T.
    Telfer, Janice C.
    Burnside, Amy S.
    Schneider, Sallie S.
    Alfandari, Dominique
    Baker, Ryan L.
    Saiju, Aman
    Nodiff, Sam
    Arcaro, Kathleen F.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection
    Pullen, Krista M.
    Atyeo, Caroline
    Collier, Ai-Ris Y.
    Gray, Kathryn J.
    Belfort, Mandy B.
    Lauffenburger, Douglas A.
    Edlow, Andrea G.
    Alter, Galit
    CELL REPORTS, 2021, 37 (06):
  • [40] Antibody Response after SARS-CoV-2 Infection with the Delta and Omicron Variant
    Blaszczuk, Agata
    Michalski, Aleksander
    Sikora, Dominika
    Malm, Maria
    Drop, Bartlomiej
    Polz-Dacewicz, Malgorzata
    VACCINES, 2022, 10 (10)
12345